January 22, 2021
The Worldwide Network for Innovation in Clinical Education and Research (WNICER) congratulates the ATTACC Trial team on the release of interim results that show full-dose blood thinners decreased need for life support and improved outcomes in hospitalized COVID-19 patients. The WNICER Network played an integral role in this multinational clinical trial led by Drs. Ryan Zarychanski and Patrick Lawler. WNICER acknowledges the contributions of its members: University Health Network’s Peter Munk Cardiac Centre under the leadership of Drs. Patrick Lawler and Michael Farkouh; University of Chicago; Mayo Clinic; The Brazilian clinical network led by Dr. José Nicolau of University of São Paulo’s InCor Heart Institute; and The Mexican clinical network led by Dr. Jorge Escobedo of the National Autonomous University of Mexico.. See press release below.